ENRIQUE GARCIA-SAYAN to Treatment Outcome
This is a "connection" page, showing publications ENRIQUE GARCIA-SAYAN has written about Treatment Outcome.
Connection Strength
0.186
-
Initial experience with the fourth generation MitraClip?: Outcomes, procedural aspects, and considerations for device selection. Catheter Cardiovasc Interv. 2021 10; 98(4):E626-E636.
Score: 0.056
-
A Woman in Her 40s With Non-ST-Elevation Myocardial Infarction. JAMA Cardiol. 2019 Feb 01; 4(2):186.
Score: 0.048
-
Residual Mitral Regurgitation Interacts With Transmitral Mean Pressure Gradient to Modify the Association With Mortality Following Transcatheter Edge-to-Edge Repair. Circ Cardiovasc Interv. 2025 Feb; 18(2):e014843.
Score: 0.018
-
Mortality Associated With Proportionality of Secondary Mitral Regurgitation After Transcatheter Mitral Valve Repair: North American Mitraclip for Functional Mitral Regurgitation Registry. Am J Cardiol. 2024 02 15; 213:99-105.
Score: 0.017
-
Rates, predictors, and outcomes of early readmissions after tricuspid valve surgery. J Card Surg. 2020 Aug; 35(8):1848-1855.
Score: 0.013
-
First-in-Human Report of MitraClip G4 Implantation for Torrential Tricuspid Regurgitation and Severe Secondary Mitral Regurgitation. JACC Cardiovasc Interv. 2020 07 13; 13(13):1599-1602.
Score: 0.013
-
First-in-human report of MitraClip G4 implantation for severe degenerative mitral regurgitation. Catheter Cardiovasc Interv. 2020 09 01; 96(3):E395-E397.
Score: 0.013
-
Safety of adenosine pharmacologic stress myocardial perfusion imaging in orthotopic cardiac transplant recipients: a single center experience of 102 transplant patients. Int J Cardiovasc Imaging. 2011 Oct; 27(7):1105-11.
Score: 0.007